Todd Pettingill is Vice President of Business Development and Strategy at OmniAb. Prior to OmniAb, Mr. Pettingill joined Ligand Pharmaceuticals in 2013 and served in various roles including Mergers and Acquisitions, Business Development, Strategy and Investor Relations. At Ligand, Mr. Pettingill participated or led more than 10 company and asset acquisitions or divestitures, including acquisitions which formed the scientific basis and original business foundation of OmniAb. Previously, Mr. Pettingill was a member of the Mergers and Acquisitions investment banking group at Deutsche Bank. Prior to Deutsche Bank, he began his career at PricewaterhouseCoopers, where he provided accounting advisory and valuation services to the Biotechnology and Venture Capital industries. Mr. Pettingill holds an MBA in Finance from the UCLA Anderson School of Management and a BS in Accounting from Brigham Young University. Mr. Pettingill holds the CFA designation.
